Results 31 to 40 of about 4,414 (225)
The recently introduced novel drug combinations for the treatment of COPD are based on long-acting beta-agonists (vilantererol / umeclidinum bromide) and long-acting anticholinergics (olodaterol / tiotropium bromide).
E. G. Kosolapov +5 more
doaj +1 more source
Pneumococcal disease is a major threat to public health globally, impacting individuals across all age groups, particularly infants and elderly individuals.
Fang-Feng Chiu +6 more
doaj +1 more source
Background: Left atrial appendage closure (LAAC) is an established therapy for patients with atrial fibrillation (AF); however, there is a limited understanding of LAAC in elderly patients (≥75 years old).
Shaojie Han +5 more
doaj +1 more source
Editorial to "Initial experiences and technical insights of pulmonary vein isolation with FARAPULSE pulsed field ablation in patients implanted with WATCHMAN left atrial appendage closure devices: The first report in Japan". [PDF]
Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
Fukunaga M.
europepmc +2 more sources
DNA methylation governs the dynamic regulation of inflammation by apoptotic cells during efferocytosis [PDF]
Efficient clearance of apoptotic cells (AC) is pivotal in preventing autoimmunity and is a potent immunosuppressive stimulus. However, activation of cells prior to apoptosis abolishes their immunoregulatory properties.
Brown, MA +4 more
core +1 more source
COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
In accordance with currently accepted recommendations for the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), both monotherapy with long-acting anticholinergics (LAAC) or combined therapy (LAAC / long-acting beta-agonists, LABA ...
E. G. Kosolapov +3 more
doaj +1 more source
Left atrial appendage closure (LAAC) devices can be inadvertently released into unfavorable locations, which may allow them to migrate to a different position within the left atrial appendage or embolize from the heart into the aorta.
Saihua Wang +5 more
doaj +1 more source
Background Recent publications reached conflicting conclusions about the cost‐effectiveness of left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, Marlborough, MA) for stroke risk reduction in nonvalvular atrial fibrillation
Vivek Y. Reddy +4 more
doaj +1 more source
La puerta califal del castillo de Gormaz
Este artículo aborda el análisis parcial de un monumento emblemático de la arquitectura militar andalusí, muy citado como ejemplo de la arquitectura califal pero que aún hoy adolece de un estudio en profundidad y con metodología adecuada para identificar
Antonio Almagro
doaj +1 more source
Background Percutaneous left atrial appendage closure (LAAC) has been suggested as an alternative to long‐term oral anticoagulation for nonvalvular atrial fibrillation, but comparative data remain scarce. We aimed to assess ischemic and bleeding outcomes
Angelo Oliva +15 more
doaj +1 more source

